Zynex, Inc. (NASDAQ: ZYXI) Stock Competitors & Peer Comparison
See ZYXI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ZYXI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZYXI | $0.13 | +140.38% | 3.8M | -0.05 | -$2.41 | N/A |
| MCK | $859.92 | -1.04% | 100.7B | 21.08 | $40.82 | +0.38% |
| COR | $312.52 | -0.41% | 60.8B | 18.23 | $17.15 | +0.77% |
| CAH | $235.66 | +0.21% | 55.2B | 22.59 | $10.43 | +0.87% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $89.52 | -0.28% | 10.2B | 16.86 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| PBH | $50.04 | -2.61% | 2.4B | 11.32 | $4.42 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| ACH | $1.07 | +12.52% | 81.9M | 1.57 | $0.68 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
ZYXI vs MCK Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, MCK has a market cap of 100.7B. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while MCK trades at $859.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas MCK's P/E ratio is 21.08. In terms of profitability, ZYXI's ROE is +11.38%, compared to MCK's ROE of -1.94%. Regarding short-term risk, ZYXI is less volatile compared to MCK. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
ZYXI vs COR Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, COR has a market cap of 60.8B. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while COR trades at $312.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas COR's P/E ratio is 18.23. In terms of profitability, ZYXI's ROE is +11.38%, compared to COR's ROE of +1.06%. Regarding short-term risk, ZYXI is less volatile compared to COR. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
ZYXI vs CAH Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, CAH has a market cap of 55.2B. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while CAH trades at $235.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas CAH's P/E ratio is 22.59. In terms of profitability, ZYXI's ROE is +11.38%, compared to CAH's ROE of -0.60%. Regarding short-term risk, ZYXI is less volatile compared to CAH. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
ZYXI vs ABC Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas ABC's P/E ratio is 21.92. In terms of profitability, ZYXI's ROE is +11.38%, compared to ABC's ROE of +1.06%. Regarding short-term risk, ZYXI is less volatile compared to ABC. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
ZYXI vs HSIC Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, HSIC has a market cap of 10.2B. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while HSIC trades at $89.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas HSIC's P/E ratio is 16.86. In terms of profitability, ZYXI's ROE is +11.38%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, ZYXI is less volatile compared to HSIC. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
ZYXI vs PDCO Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas PDCO's P/E ratio is 20.48. In terms of profitability, ZYXI's ROE is +11.38%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, ZYXI is similarly volatile compared to PDCO. This indicates similar risk in terms of short-term price fluctuations for ZYXI.Check PDCO's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
ZYXI vs PBH Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while PBH trades at $50.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas PBH's P/E ratio is 11.32. In terms of profitability, ZYXI's ROE is +11.38%, compared to PBH's ROE of +0.09%. Regarding short-term risk, ZYXI is less volatile compared to PBH. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check PBH's competition here
Owens & Minor, Inc. (NYSE: OMI)
ZYXI vs OMI Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas OMI's P/E ratio is -0.47. In terms of profitability, ZYXI's ROE is +11.38%, compared to OMI's ROE of +0.63%. Regarding short-term risk, ZYXI is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check OMI's competition here
Accendra Health, Inc. (NYSE: ACH)
ZYXI vs ACH Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, ACH has a market cap of 81.9M. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while ACH trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas ACH's P/E ratio is 1.57. In terms of profitability, ZYXI's ROE is +11.38%, compared to ACH's ROE of +0.63%. Regarding short-term risk, ZYXI is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
ZYXI vs HX Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas HX's P/E ratio is -1.84. In terms of profitability, ZYXI's ROE is +11.38%, compared to HX's ROE of -1.07%. Regarding short-term risk, ZYXI is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check HX's competition here
111, Inc. (NASDAQ: YI)
ZYXI vs YI Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, YI has a market cap of 31.5M. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while YI trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas YI's P/E ratio is -2.58. In terms of profitability, ZYXI's ROE is +11.38%, compared to YI's ROE of +0.14%. Regarding short-term risk, ZYXI is less volatile compared to YI. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
ZYXI vs WGRX Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas WGRX's P/E ratio is -0.33. In terms of profitability, ZYXI's ROE is +11.38%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, ZYXI is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check WGRX's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
ZYXI vs MEDS Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, MEDS has a market cap of 3.9M. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while MEDS trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas MEDS's P/E ratio is N/A. In terms of profitability, ZYXI's ROE is +11.38%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, ZYXI is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check MEDS's competition here
ZeroStack Corp. (NASDAQ: ZSTK)
ZYXI vs ZSTK Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, ZSTK has a market cap of 2.1M. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while ZSTK trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas ZSTK's P/E ratio is -0.04. In terms of profitability, ZYXI's ROE is +11.38%, compared to ZSTK's ROE of -3.82%. Regarding short-term risk, ZYXI is less volatile compared to ZSTK. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check ZSTK's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
ZYXI vs SNYR Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, SNYR has a market cap of 1.6M. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while SNYR trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas SNYR's P/E ratio is -0.11. In terms of profitability, ZYXI's ROE is +11.38%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, ZYXI is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
ZYXI vs RDGT Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, RDGT has a market cap of 694.7K. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while RDGT trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas RDGT's P/E ratio is -0.01. In terms of profitability, ZYXI's ROE is +11.38%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, ZYXI is less volatile compared to RDGT. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
ZYXI vs CVET Comparison August 2026
Zynex, Inc. (NASDAQ: ZYXI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZYXI stands at 3.8M. In comparison, CVET has a market cap of 0. Regarding current trading prices, ZYXI is priced at $0.13 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZYXI currently has a P/E ratio of -0.05, whereas CVET's P/E ratio is -69.97. In terms of profitability, ZYXI's ROE is +11.38%, compared to CVET's ROE of -0.06%. Regarding short-term risk, ZYXI is less volatile compared to CVET. This indicates lower risk in terms of short-term price fluctuations for ZYXI.Check CVET's competition here